Cargando…

The Immune Response to SARS-CoV-2 Vaccination: Insights Learned From Adult Patients With Common Variable Immune Deficiency

CVID patients have an increased susceptibility to vaccine-preventable infections. The question on the potential benefits of immunization of CVID patients against SARS-CoV-2 offered the possibility to analyze the defective mechanisms of immune responses to a novel antigen. In CVID, as in immunocompet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quinti, Isabella, Locatelli, Franco, Carsetti, Rita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807657/ https://www.ncbi.nlm.nih.gov/pubmed/35126372 http://dx.doi.org/10.3389/fimmu.2021.815404

Ejemplares similares

The immune system of children: the key to understanding SARS-CoV-2 susceptibility?
por: Carsetti, Rita, et al.
Publicado: (2020)

IGA Antibody Induced by Immunization With Pneumococcal Polysaccharides Is a Prognostic Tool in Common Variable Immune Deficiencies
por: Pulvirenti, Federica, et al.
Publicado: (2020)

Longitudinal Study on Health-Related Quality of Life in a Cohort of 96 Patients with Common Variable Immune Deficiencies
por: Tabolli, Stefano, et al.
Publicado: (2014)

T-Cell Defects Associated to Lack of Spike-Specific Antibodies after BNT162b2 Full Immunization Followed by a Booster Dose in Patients with Common Variable Immune Deficiencies
por: Pulvirenti, Federica, et al.
Publicado: (2022)

The BNT162b2 vaccine induces humoral and cellular immune memory to SARS-CoV-2 Wuhan strain and the Omicron variant in children 5 to 11 years of age
por: Cinicola, Bianca Laura, et al.
Publicado: (2022)

Impaired memory B-cell response to the Pfizer-BioNTech COVID-19 vaccine in patients with common variable immunodeficiency
por: Fernandez Salinas, Ane, et al.
Publicado: (2022)

IgA Antibodies and IgA Deficiency in SARS-CoV-2 Infection
por: Quinti, Isabella, et al.
Publicado: (2021)

Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases
por: Carsetti, Rita, et al.
Publicado: (2020)

SARS-CoV-2 pre-exposure prophylaxis with tixagevimab/cilgavimab (AZD7442) provides protection in inborn errors of immunity with antibody defects: a real-world experience
por: Pulvirenti, Federica, et al.
Publicado: (2023)

Editorial: Trained Immunity-Based Vaccines
por: Subiza, Jose Luis, et al.
Publicado: (2021)

Histology of Interstitial Lung Disease in Common Variable Immune Deficiency
por: Dhalla, Fatima, et al.
Publicado: (2020)

SARS-CoV-2 Vaccine Induced Atypical Immune Responses in Antibody Defects: Everybody Does their Best
por: Salinas, Ane Fernandez, et al.
Publicado: (2021)

Assessment of Immunogenicity of Adjuvanted Quadrivalent Inactivated Influenza Vaccine in Healthy People and Patients With Common Variable Immune Deficiency
por: Kostinova, Aristitsa Mikhailovna, et al.
Publicado: (2020)

Modulatory Effects of Antibody Replacement Therapy to Innate and Adaptive Immune Cells
por: Quinti, Isabella, et al.
Publicado: (2017)

B Cell Response Induced by SARS-CoV-2 Infection Is Boosted by the BNT162b2 Vaccine in Primary Antibody Deficiencies
por: Pulvirenti, Federica, et al.
Publicado: (2021)

Infection and Immune Memory: Variables in Robust Protection by Vaccines Against SARS-CoV-2
por: Ahluwalia, Pankaj, et al.
Publicado: (2021)

Potential Cross-Reactive Immunity to SARS-CoV-2 From Common Human Pathogens and Vaccines
por: Reche, Pedro A.
Publicado: (2020)

Responses to SARS-CoV-2 Vaccines of Patients with Common Variable Immune Deficiencies and X-linked Agammaglobulinemia
por: Carrabba, Maria, et al.
Publicado: (2022)

Immunity to SARS-CoV-2: Lessons Learned
por: Fergie, Jaime, et al.
Publicado: (2021)

Conservation and Evolution of Antigenic Determinants of SARS-CoV-2: An Insight for Immune Escape and Vaccine Design
por: Jaiswal, Varun, et al.
Publicado: (2022)

Evaluation of Humoral and Cellular Immune Responses to the SARS-CoV-2 Vaccine in Patients With Common Variable Immunodeficiency Phenotype and Patient Receiving B-Cell Depletion Therapy
por: Antolí, Arnau, et al.
Publicado: (2022)

Evaluation of Immune and Vaccine Competence in Steroid-Sensitive Nephrotic Syndrome Pediatric Patients
por: Colucci, Manuela, et al.
Publicado: (2021)

Manufacture of Immunoglobulin Products for Patients with Primary Antibody Deficiencies – The Effect of Processing Conditions on Product Safety and Efficacy
por: Farrugia, Albert, et al.
Publicado: (2014)

SARS-CoV-2 Variants, Vaccines, and Host Immunity
por: Mistry, Priyal, et al.
Publicado: (2022)

Functional CVIDs phenotype clusters identified by the integration of immune parameters after BNT162b2 boosters
por: Piano Mortari, Eva, et al.
Publicado: (2023)

Superior humoral immunity in vaccinated SARS-CoV-2 convalescence as compared to SARS-COV-2 infection or vaccination
por: Paniskaki, Krystallenia, et al.
Publicado: (2022)

Case Report: Precision COVID-19 Immunization Strategy to Overcome Individual Fragility: A Case of Generalized Lipodystrophy Type 4
por: Zaffina, Salvatore, et al.
Publicado: (2022)

Editorial: The Complexity of Primary Antibody Deficiencies
por: Quinti, Isabella, et al.
Publicado: (2021)

Gastric Cancer Is the Leading Cause of Death in Italian Adult Patients With Common Variable Immunodeficiency
por: Pulvirenti, Federica, et al.
Publicado: (2018)

Cellular immune response to SARS-CoV-2 in patients with primary antibody deficiencies
por: Mizera, Dorota, et al.
Publicado: (2023)

Decline of gastric cancer mortality in common variable immunodeficiency in the years 2018-2022
por: Milito, Cinzia, et al.
Publicado: (2023)

Humoral and cellular immunity to SARS-COV-2 after vaccination with mRNA vaccines in PLWH with discordant immune response. Influence of the vaccine administered
por: López-Cortés, Luis F., et al.
Publicado: (2023)

Antibody response following the third and fourth SARS-CoV-2 vaccine dose in individuals with common variable immunodeficiency
por: Nielsen, Bibi Uhre, et al.
Publicado: (2022)

Editorial: Mucosal immunity to HIV and SARS-CoV-2 infection and vaccination
por: Bomsel, Morgane, et al.
Publicado: (2023)

Adaptive Immune Responses and Immunity to SARS-CoV-2
por: Primorac, Dragan, et al.
Publicado: (2022)

Cellular immunity in COVID-19 and other infections in Common variable immunodeficiency
por: Løken, Ragnhild Øye, et al.
Publicado: (2023)

Health-Related Quality of Life and Patients’ Empowerment in the Health Care of Primary Immune Deficiencies
por: Quinti, Isabella, et al.
Publicado: (2017)

Proteomic and Metabolomic Signatures Associated With the Immune Response in Healthy Individuals Immunized With an Inactivated SARS-CoV-2 Vaccine
por: Wang, Yi, et al.
Publicado: (2022)

Could BCG Vaccination Induce Protective Trained Immunity for SARS-CoV-2?
por: Covián, Camila, et al.
Publicado: (2020)

The Mucosal and Serological Immune Responses to the Novel Coronavirus (SARS-CoV-2) Vaccines
por: Chan, Renee W. Y., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_67m7ameh243d50pnjc2ckhlhuf